This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
MOUSE ANTI HUMAN CD30:Biotin
catalog :
MCA6271B
quantity :
0.1 mg
price :
316 USD
clonality :
monoclonal
host :
mouse
conjugate :
biotin
clone name :
D02-6E11
reactivity :
human
product information
Entity Type :
Monoclonal Antibody
Entity Category :
Antibodies
ProductCode :
MCA6271B
Description :
MOUSE ANTI HUMAN CD30:Biotin
Specificity :
CD30
TargetSpecies :
Human
Host :
Mouse
Format :
Biotin
Conjugate/Tag :
Biotin
Isotypes :
IgG1
Applications :
E
ApplicationTypes :
ELISA
Clone :
D02-6E11
Quantity :
0.1 mg
Quantity Value :
0.1
Quantity Type :
mg
GO Accessions :
GO:0043065,GO:0045556,GO:0008285,GO:0005737,GO:0042535,GO:0005886,GO:0016021
GOTerms :
bacterial inner membrane,cell membrane,cytoplasmic membrane,GO:0005904,inner endospore membrane,juxtamembrane,plasma membrane lipid bilayer,plasmalemma,transmembrane,down regulation of cell proliferation,downregulation of cell proliferation,down-regulation of cell proliferation,inhibition of cell proliferation,activation of tumor necrosis factor biosynthetic process,positive regulation of TNF alpha biosynthesis,positive regulation of TNF alpha biosynthetic process,positive regulation of TNF biosynthesis,positive regulation of TNF biosynthetic process,positive regulation of TNF-alpha biosynthesis,positive regulation of TNF-alpha biosynthetic process,positive regulation of tumor necrosis factor anabolism,positive regulation of tumor necrosis factor biosynthesis,positive regulation of tumor necrosis factor formation,positive regulation of tumor necrosis factor synthesis,positive regulation of tumor necrosis factor-alpha biosynthesis,positive regulation of tumor necrosis factor-alpha biosynthetic process,stimulation of tumor necrosis factor biosynthetic process,up regulation of tumor necrosis factor biosynthetic process,upregulation of tumor necrosis factor biosynthetic process,up-regulation of tumor necrosis factor biosynthetic process,activation of apoptosis,stimulation of apoptosis,up regulation of apoptosis,upregulation of apoptosis,up-regulation of apoptosis,activation of TRAIL biosynthetic process,positive regulation of TRAIL anabolism,positive regulation of TRAIL biosynthesis,positive regulation of TRAIL formation,positive regulation of TRAIL synthesis,stimulation of TRAIL biosynthetic process,up regulation of TRAIL biosynthetic process,upregulation of TRAIL biosynthetic process,up-regulation of TRAIL biosynthetic process
Uniprot Accessions :
P28908
Gene :
TNFRSF8
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=943
Published Synonyms :
TNFRSF8
Entity Formats :
Biotin
UNSPSC :
41116161
Concentration :
IgG concentration 0.1 mg/ml
Product Form :
Purified IgG conjugated to Biotin - liquid
PriceGBP :
225
PriceEUR :
316
PriceUSD :
316 USD
PriceCHF :
344
PriceSEK :
3444
PriceNOK :
3462
PriceDKK :
2356
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.